Page last updated: 2024-10-23

bumetanide and Anemia, Hemolytic, Congenital

bumetanide has been researched along with Anemia, Hemolytic, Congenital in 2 studies

Anemia, Hemolytic, Congenital: Hemolytic anemia due to various intrinsic defects of the erythrocyte.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Stewart, AK1
Vandorpe, DH1
Heneghan, JF1
Chebib, F1
Stolpe, K1
Akhavein, A1
Edelman, EJ1
Maksimova, Y1
Gallagher, PG1
Alper, SL1
Stewart, GW1
Ellory, JC1

Other Studies

2 other studies available for bumetanide and Anemia, Hemolytic, Congenital

ArticleYear
The GPA-dependent, spherostomatocytosis mutant AE1 E758K induces GPA-independent, endogenous cation transport in amphibian oocytes.
    American journal of physiology. Cell physiology, 2010, Volume: 298, Issue:2

    Topics: 4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid; Ambystoma mexicanum; Amino Acid Sequence; Amphibia

2010
A family with mild hereditary xerocytosis showing high membrane cation permeability at low temperatures.
    Clinical science (London, England : 1979), 1985, Volume: 69, Issue:3

    Topics: Adult; Aged; Anemia, Hemolytic, Congenital; Anemia, Hemolytic, Congenital Nonspherocytic; Biological

1985